These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 16862241)

  • 1. The role of neurotensin in central nervous system pathophysiology: what is the evidence?
    St-Gelais F; Jomphe C; Trudeau LE
    J Psychiatry Neurosci; 2006 Jul; 31(4):229-45. PubMed ID: 16862241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin, schizophrenia, and antipsychotic drug action.
    Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotensin/dopamine interactions].
    Kitabgi P; Hervé D; Studler JM; Tramu G; Rostène W; Tassin JP
    Encephale; 1989; 15 Spec No():91-4. PubMed ID: 2545433
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of neurotensin in physiologic and pathologic processes.
    Mustain WC; Rychahou PG; Evers BM
    Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):75-82. PubMed ID: 21124211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin analogs indications for use as potential antipsychotic compounds.
    McMahon BM; Boules M; Warrington L; Richelson E
    Life Sci; 2002 Jan; 70(10):1101-19. PubMed ID: 11848295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse roles of neurotensin agonists in the central nervous system.
    Boules M; Li Z; Smith K; Fredrickson P; Richelson E
    Front Endocrinol (Lausanne); 2013; 4():36. PubMed ID: 23526754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Here today and not gone tomorrow: the curse of chronic pain and other central sensitization syndromes.
    Stahl SM
    J Clin Psychiatry; 2003 Aug; 64(8):863-4. PubMed ID: 12926998
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin?
    Fredrickson P; Boules M; Lin SC; Richelson E
    Psychiatr Clin North Am; 2005 Sep; 28(3):737-51, 746. PubMed ID: 16122577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesocortical neurotensin/dopamine system: is it involved in the pathogenesis of schizophrenia?
    Satoh K
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):503-6. PubMed ID: 1722262
    [No Abstract]   [Full Text] [Related]  

  • 11. The regulatory role of neurotensin on the hypothalamic-anterior pituitary axons: emphasis on the control of thyroid-related functions.
    Stolakis V; Kalafatakis K; Botis J; Zarros A; Liapi C
    Neuropeptides; 2010 Feb; 44(1):1-7. PubMed ID: 19878995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
    Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
    Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.
    Kasckow J; Nemeroff CB
    Regul Pept; 1991 Oct; 36(2):153-64. PubMed ID: 1666685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
    Lambert PD; Gross R; Nemeroff CB; Kilts CD
    Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central dopaminergic receptors (Part II): pathophysiological and therapeutic considerations].
    Bordet R
    Rev Neurol (Paris); 2004 Oct; 160(10):986-92. PubMed ID: 15492728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive analogs of neurotensin: focus on CNS effects.
    Boules M; Fredrickson P; Richelson E
    Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurotensin--structure, origin and biological function].
    Kulińska-Niedziela I; Paluszak J
    Postepy Hig Med Dosw; 1997; 51(3):329-42. PubMed ID: 9333784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
    Li Z; Boules M; Williams K; Peris J; Richelson E
    Brain Res; 2010 Jan; 1311():28-36. PubMed ID: 19948149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the role of heteroreceptor complexes in the central nervous system.
    Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
    Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin: an endogenous psychostimulant?
    Bérod A; Rostène W
    Curr Opin Pharmacol; 2002 Feb; 2(1):93-8. PubMed ID: 11786315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.